Abstract
The receptor for advanced glycation end products (RAGE) mediates a variety of inflammatory responses in renal diseases, but its role in renal ischemia/reperfusion (I/R) injury is unknown. We showed that during renal I/R, RAGE ligands HMGB1 and S100B are expressed. However, RAGE deficiency does not affect renal injury and function upon I/R-induced injury. Copyright (C) 2011 S. Karger AG, Basel
Original language | English |
---|---|
Pages (from-to) | 80-85 |
Journal | Journal of innate immunity |
Volume | 4 |
Issue number | 1 |
DOIs | |
Publication status | Published - 2012 |